MEG3 and neoplasm: In contrast, cell lines and tumours with GTL2 promoter DMR and IG-DMR hypermethylation did not show any differences from normal controls at the CpG-rich region upstream of the DLK1 promoter nor at the two CpG-rich regions downstream of the DLK1 promoter.